BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tyrrell BE, Sayce AC, Warfield KL, Miller JL, Zitzmann N. Iminosugars: Promising therapeutics for influenza infection. Crit Rev Microbiol 2017;43:521-45. [PMID: 27931136 DOI: 10.1080/1040841X.2016.1242868] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu X, Zhang QY, Chu XY, Quan Y, Lv BM, Zhang HY. Facilitating Antiviral Drug Discovery Using Genetic and Evolutionary Knowledge. Viruses 2021;13:2117. [PMID: 34834924 DOI: 10.3390/v13112117] [Reference Citation Analysis]
2 Dhara D, Dhara A, Bennett J, Murphy PV. Cyclisations and Strategies for Stereoselective Synthesis of Piperidine Iminosugars. Chem Rec 2021;21:2958-79. [PMID: 34713557 DOI: 10.1002/tcr.202100221] [Reference Citation Analysis]
3 Zamoner LOB, Aragão-Leoneti V, Carvalho I. Iminosugars: Effects of Stereochemistry, Ring Size, and N-Substituents on Glucosidase Activities. Pharmaceuticals (Basel) 2019;12:E108. [PMID: 31336868 DOI: 10.3390/ph12030108] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
4 Hernández D, Porras M, Boto A. Structural diversity using amino acid "Customizable Units": conversion of hydroxyproline (Hyp) into nitrogen heterocycles. Amino Acids 2022. [PMID: 35414005 DOI: 10.1007/s00726-022-03159-z] [Reference Citation Analysis]
5 Glanz VY, Myasoedova VA, Grechko AV, Orekhov AN. Inhibition of sialidase activity as a therapeutic approach. Drug Des Devel Ther 2018;12:3431-7. [PMID: 30349196 DOI: 10.2147/DDDT.S176220] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
6 Jairaj A, Shirisha P, Abdul MSM, Fatima U, Tiwari RVC, Moothedath M. Adult Immunization - Need of the Hour. J Int Soc Prev Community Dent 2018;8:475-81. [PMID: 30596036 DOI: 10.4103/jispcd.JISPCD_347_18] [Reference Citation Analysis]
7 Warfield KL, Schaaf KR, DeWald LE, Spurgers KB, Wang W, Stavale E, Mendenhall M, Shilts MH, Stockwell TB, Barnard DL, Ramstedt U, Das SR. Lack of selective resistance of influenza A virus in presence of host-targeted antiviral, UV-4B. Sci Rep 2019;9:7484. [PMID: 31097731 DOI: 10.1038/s41598-019-43030-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
8 Margolin E, Crispin M, Meyers A, Chapman R, Rybicki EP. A Roadmap for the Molecular Farming of Viral Glycoprotein Vaccines: Engineering Glycosylation and Glycosylation-Directed Folding. Front Plant Sci 2020;11:609207. [PMID: 33343609 DOI: 10.3389/fpls.2020.609207] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Marti L, Lia A, Reca IB, Roversi P, Santino A, Zitzmann N. In Planta Preliminary Screening of ER Glycoprotein Folding Quality Control (ERQC) Modulators. Int J Mol Sci 2018;19:E2135. [PMID: 30041423 DOI: 10.3390/ijms19072135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
10 Puet A, Domínguez G, Cañada FJ, Pérez-Castells J. Amino Acid-Based Synthesis and Glycosidase Inhibition of Cyclopropane-Containing Iminosugars. ACS Omega 2020;5:31821-30. [PMID: 33344836 DOI: 10.1021/acsomega.0c04589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ma J, Zhang X, Soloveva V, Warren T, Guo F, Wu S, Lu H, Guo J, Su Q, Shen H, Solon E, Comunale MA, Mehta A, Guo JT, Bavari S, Du Y, Block TM, Chang J. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo. Antiviral Res 2018;150:112-22. [PMID: 29253498 DOI: 10.1016/j.antiviral.2017.12.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
12 Gas-Pascual E, Ichikawa HT, Sheikh MO, Serji MI, Deng B, Mandalasi M, Bandini G, Samuelson J, Wells L, West CM. CRISPR/Cas9 and glycomics tools for Toxoplasma glycobiology. J Biol Chem 2019;294:1104-25. [PMID: 30463938 DOI: 10.1074/jbc.RA118.006072] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 8.3] [Reference Citation Analysis]
13 Wolfsgruber A, Thonhofer M, Weber P, Nasseri SA, Fischer R, Schalli M, Stütz AE, Withers SG, Wrodnigg TM. N-Alkylated Iminosugar Based Ligands: Synthesis and Inhibition of Human Lysosomal β-Glucocerebrosidase. Molecules 2020;25:E4618. [PMID: 33050585 DOI: 10.3390/molecules25204618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Hayakawa M, Umeyama H, Iwadate M, Taguchi YH, Yano Y, Honda T, Itami-Matsumoto S, Kozuka R, Enomoto M, Tamori A, Kawada N, Murakami Y. Development of a novel anti-hepatitis B virus agent via Sp1. Sci Rep 2020;10:47. [PMID: 31913341 DOI: 10.1038/s41598-019-56842-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]